Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06938685 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 17, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 2 of 8 sitesv9
  2. Trial sites expanded: 5 → 8 locationsv8
  3. Site details revised at 1 of 5 sitesv7
  4. Study sites: 4 to 5v6
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 4
    • Start date changed from estimate of Sep 1, 2025 to Oct 6, 2025
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Aug 1, 2025 to Sep 1, 2025
    • Study sites: 0 to 1
    • Primary completion date: Aug 1, 2026 to Sep 1, 2026
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Start date: Jun 1, 2025 to Aug 1, 2025v2 Show 5 more changesShow less
    • Primary completion date: Jun 1, 2026 to Aug 1, 2026
    • Study completion date: Aug 1, 2026 to Oct 1, 2026
    • Eligibility criteria expanded, about 44 words
    • Secondary endpoints: 4 to 2
    • Study description expanded, about 70 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot ulcers.
Trial Details
NCT Number NCT06938685
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions
(from sponsor)		 Diabetic Foot Ulcer
Related terms Diabetic Foot
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov